Citation: K. Duncan et P. Heald, CUTANEOUS T-CELL LYMPHOMA - CENTURIES OF CONTROVERSY, Seminars in cutaneous medicine and surgery, 17(2), 1998, pp. 133-140
Citation: P. Heald, A 68-YEAR-OLD MAN WITH A RASH, DIABETES-INSIPIDUS, AND LARYNGEAL STENOSIS - XANTHOMA DISSEMINATUM, INVOLVING THE SKIN, LARYNX, AND PITUITARY-GLAND (VOL 338, PG 1138, 1998), The New England journal of medicine, 339(6), 1998, pp. 415-415
Citation: P. Heald et al., A 68-YEAR-OLD MAN WITH A RASH, DIABETES-INSIPIDUS, AND LARYNGEAL STENOSIS - XANTHOMA DISSEMINATUM, INVOLVING THE SKIN, LARYNX, AND PITUITARY-GLAND, The New England journal of medicine, 338(16), 1998, pp. 1138-1143
Citation: P. Heald et al., CONVERSION FROM CD4-CELL LYMPHOMA( TO CD8+ EXPRESSION AS A TERMINAL EVENT IN CUTANEOUS T), Journal of investigative dermatology, 110(4), 1998, pp. 642-642
Authors:
DUNCAN K
HEALD P
TALLINI G
CROTTY P
GLUSAC E
Citation: K. Duncan et al., UTILITY OF PCR AMPLIFICATION OF T-CELL RECEPTOR REARRANGEMENTS IN THEDEFINITION OF CUTANEOUS T-CELL LYMPHOMA RELAPSE, Journal of investigative dermatology, 110(4), 1998, pp. 645-645
Authors:
BERGER CL
LONGLEY BJ
IMAEDA S
CHRISTENSEN I
HEALD P
EDELSON RL
Citation: Cl. Berger et al., TUMOR-SPECIFIC PEPTIDES IN CUTANEOUS T-CELL LYMPHOMA - ASSOCIATION WITH CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX AND POSSIBLE DERIVATION FROM THE CLONOTYPIC T-CELL RECEPTOR, International journal of cancer, 76(3), 1998, pp. 304-311
Citation: C. Herrick et P. Heald, THE DYNAMIC INTERPLAY OF MALIGNANT AND BENIGN T-CELLS IN CUTANEOUS T-CELL LYMPHOMA, Dermatologic clinics, 15(1), 1997, pp. 149
Authors:
LIEPA A
BENNETT CL
YARNOLD PR
ENAS N
LOZANO J
KUZEL T
OLSON E
MARTIN A
KIM Y
DUVIC M
FRANKEL A
VONDERHEID E
BOWEN G
JEGASOTHY B
WOOD G
GORDON M
PINTERBROWN L
FIVENSON D
HEALD P
OSCROFF A
FOSS F
GLODE M
STEWART S
MOLINA A
KNOBLER E
NICHOLS J
Citation: A. Liepa et al., CHANGES IN QUALITY-OF-LIFE (QOL) FOR PATIENTS (PTS) ENROLLED IN A PHASE-III TRIAL OF TREATMENT WITH A DIPHTHERIA-TOXIN FUSION PROTEIN (DAB(389)IL-2) FOR MYCOSIS-FUNGOIDES (MF), Blood, 90(10), 1997, pp. 3924-3924
Authors:
BACHA P
FOWLIE A
GRIMALDO D
HILLIER J
OLSEN E
MARTIN A
KIM Y
DUVIC M
FRANKEL A
VONDERHEID E
BOWEN G
JEGASOTHY B
WOOD G
GORDON M
PINTERBROWN L
FIVENSON D
HEALD P
OSEROFF A
KUZEL T
FOSS F
GLODE M
STEWART S
MOLINA A
KNOBLER E
Citation: P. Bacha et al., ANTIBODY AND PHARMACOKINETIC ANALYSIS FROM A PIVOTAL TRIAL OF ONTAK(TM) (DAB(389)IL-2) FOR THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA (CTCL), Blood, 90(10), 1997, pp. 1457-1457
Authors:
KUZEL T
OLSEN E
MARTIN A
KIM Y
DUVIC M
FRANKEL A
VONDERHEID E
BOWEN G
JEGASOTHY B
WOOD G
GORDON M
PINTERBROWN L
FIVENSON D
HEALD P
OSEROFF A
FOSS F
GLODE M
STEWART S
MOLINA A
KNOBLER E
NICHOLS J
BACHA P
Citation: T. Kuzel et al., PIVOTAL PHASE-III TRIAL OF 2 DOSE LEVELS OF DAB(389)IL-2 (ONTAK(TM)) FOR THE TREATMENT OF MYCOSIS-FUNGOIDES (MF), Blood, 90(10), 1997, pp. 2607-2607
Authors:
BERGER CL
WANG N
CHRISTENSEN I
LONGLEY J
HEALD P
EDELSON RL
Citation: Cl. Berger et al., THE IMMUNE-RESPONSE TO CLASS I-ASSOCIATED TUMOR-SPECIFIC CUTANEOUS T-CELL LYMPHOMA ANTIGENS, Journal of investigative dermatology, 107(3), 1996, pp. 392-397
Authors:
KARLSSON J
BERGER C
CHRISTENSEN I
HEALD P
ROTHSTEIN D
EDELSON R
Citation: J. Karlsson et al., CD45RO STIMULATION UP-REGULATES BCL-2 ONCOGENE PRODUCTION AND PROTECTS CUTANEOUS T-CELL LYMPHOMA-CELLS FROM APOPTOSIS IN-VITRO, Journal of investigative dermatology, 106(4), 1996, pp. 299-299
Authors:
LONGLEY BJ
BERGER C
IMAEDA S
HEALD P
EDELSON R
Citation: Bj. Longley et al., TUMOR-SPECIFIC ANTIGENS ON THE MALIGNANT-CELLS OF CUTANEOUS T-CELL LYMPHOMA ARE DERIVED FROM CLONE SPECIFIC T-CELL RECEPTOR CHAINS, Journal of investigative dermatology, 106(4), 1996, pp. 715-715
Citation: P. Heald et al., CONCOMITANT PUSTULAR PSORIASIS AND CUTANEOUS T-CELL LYMPHOMA PRESENTING AS A SINGLE ILLNESS IN 4 PATIENTS, Journal of investigative dermatology, 106(4), 1996, pp. 733-733
Authors:
LONGLEY J
TYRRELL L
LU SZ
FARRELL J
DING TG
YAN SL
SALLEE D
HEALD P
BERGER C
TIGELAAR R
EDELSON R
Citation: J. Longley et al., MALIGNANT AND NORMAL T-CELLS SHOW RANDOM USE OF T-CELL RECEPTOR-ALPHACHAIN VARIABLE REGIONS IN PATIENTS WITH CUTANEOUS T-CELL LYMPHOMA, Journal of investigative dermatology, 105(1), 1995, pp. 62-64
Authors:
BERGER CL
WANG NC
HEALD P
CHRISTENSEN I
EDELSON R
Citation: Cl. Berger et al., TUMOR-SPECIFIC CYTOLYTIC CD8 LINES AND CLONES ISOLATED FROM CUTANEOUST-CELL LYMPHOMA (CTCL) PATIENTS, Journal of investigative dermatology, 104(4), 1995, pp. 646-646
Citation: P. Heald et al., IMMUNOPHENOTYPING AND IMMUNOGENOTYPING IN THE ASSESSMENT OF PERIPHERAL-BLOOD INVOLVEMENT FROM CTCL, Journal of investigative dermatology, 104(4), 1995, pp. 662-662
Authors:
WOOD GS
TUNG RM
HAEFFNER AC
CROOKS CF
LIAO SY
OROZCO R
VEELKEN H
KADIN ME
KOH H
HEALD P
BARNHILL RL
SKLAR J
Citation: Gs. Wood et al., DETECTION OF CLONAL T-CELL RECEPTOR-GAMMA GENE REARRANGEMENTS IN EARLY MYCOSIS-FUNGOIDES SEZARY-SYNDROME BY POLYMERASE CHAIN-REACTION AND DENATURING GRADIENT GEL-ELECTROPHORESIS, Journal of investigative dermatology, 103(1), 1994, pp. 34-41
Citation: S. Yan et al., PROLIFER4TIVE RESPONSES OF CD8 LYMPHOCYTES TO PURIFIED MALIGNANT-CELLS IN PATIENTS WITH LEUKEMIC CUTANEOUS T-CELL LYMPHOMA, Journal of investigative dermatology, 102(4), 1994, pp. 629-629
Citation: P. Heald et al., CUTANEOUS LYMPHOCYTE SEQUESTRATION AS A CAUSE OF KAPOSIS VARICELLIFORM ERUPTION, Journal of investigative dermatology, 102(4), 1994, pp. 634-634